Viewing Study NCT05315167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-20 @ 1:35 PM
Study NCT ID: NCT05315167
Status: RECRUITING
Last Update Posted: 2024-12-17
First Post: 2022-03-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
None Advanced Solid Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Maximum tolerated dose View
None Recommended Phase 2 dose View
None Dose Escalation View
None Hematopoietic progenitor kinase 1 View
None PRJ1-3024 View